Unraveling tumor microenvironment of small-cell lung cancer: Implications for immunotherapy
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Unraveling tumor microenvironment of small-cell lung cancer: Implications for immunotherapy
Authors
Keywords
-
Journal
SEMINARS IN CANCER BIOLOGY
Volume 86, Issue -, Pages 117-125
Publisher
Elsevier BV
Online
2022-09-30
DOI
10.1016/j.semcancer.2022.09.005
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A phase II, open-label, single-arm trial of carboplatin plus etoposide with bevacizumab and atezolizumab in patients with extended-stage small-cell lung cancer (CeLEBrATE study): background, design and rationale
- (2022) Elisa Andrini et al. Future Oncology
- Metabolic reservoir cycles in cancer
- (2022) Cissy Zhang et al. SEMINARS IN CANCER BIOLOGY
- Ferroptosis, necroptosis, and pyroptosis in the tumor microenvironment: Perspectives for immunotherapy of SCLC
- (2022) Xing Niu et al. SEMINARS IN CANCER BIOLOGY
- Historical perspective of tumor glycolysis: A century with Otto Warburg
- (2022) Giulia Bononi et al. SEMINARS IN CANCER BIOLOGY
- Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities
- (2021) Carl M. Gay et al. CANCER CELL
- Metabolic support of tumour-infiltrating regulatory T cells by lactic acid
- (2021) McLane J. Watson et al. NATURE
- Glutaminolysis-induced mTORC1 activation drives non-alcoholic steatohepatitis progression
- (2021) Noemí Cabré et al. JOURNAL OF HEPATOLOGY
- Cell-programmed nutrient partitioning in the tumour microenvironment
- (2021) Bradley I. Reinfeld et al. NATURE
- Hypoxia Supports Differentiation of Terminally Exhausted CD8 T Cells
- (2021) Nadia Bannoud et al. Frontiers in Immunology
- Mechanisms of Metabolic Reprogramming in Cancer Cells Supporting Enhanced Growth and Proliferation
- (2021) Chelsea Schiliro et al. Cells
- Inhibition of LDH-A by Oxamate Enhances the Efficacy of Anti-PD-1 Treatment in an NSCLC Humanized Mouse Model
- (2021) Tianyun Qiao et al. Frontiers in Oncology
- Extracellular acidity in tumor tissue upregulates programmed cell death protein 1 expression on tumor cells via proton‐sensing G protein‐coupled receptors
- (2021) Daichi Mori et al. INTERNATIONAL JOURNAL OF CANCER
- Lactic acid in macrophage polarization: The significant role in inflammation and cancer
- (2021) Hai-cun Zhou et al. INTERNATIONAL REVIEWS OF IMMUNOLOGY
- Knockdown of lncRNA HIF1A-AS2 increases drug sensitivity of SCLC cells in association with autophagy
- (2021) Ebru Güçlü et al. MEDICAL ONCOLOGY
- Targeting HIF-1 alpha transcriptional activity drives cytotoxic immune effector cells into melanoma and improves combination immunotherapy
- (2021) Audrey Lequeux et al. ONCOGENE
- Twenty-third Heidelberger Symposium on cancer research
- (2021) Max Costa SEMINARS IN CANCER BIOLOGY
- Targeting the tumor microenvironment of pancreatic ductal adenocarcinoma using nano-phytomedicines
- (2021) Bala Prabhakar Girish et al. SEMINARS IN CANCER BIOLOGY
- Recent progress of autophagy signaling in tumor microenvironment and its targeting for possible cancer therapeutics
- (2021) Subhadip Mukhopadhyay et al. SEMINARS IN CANCER BIOLOGY
- Chemotherapy resistance in epithelial ovarian cancer: Mechanisms and emerging treatments
- (2021) Claudia Marchetti et al. SEMINARS IN CANCER BIOLOGY
- Efficacy of first-line atezolizumab combination therapy in patients with non-small cell lung cancer receiving proton pump inhibitors: post hoc analysis of IMpower150
- (2021) Ashley M. Hopkins et al. BRITISH JOURNAL OF CANCER
- Novel strategies to improve tumour therapy by targeting the proteins MCT1, MCT4 and LAT1
- (2021) Yang Wang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- The role of tumor microenvironment and exosomes in dormancy and relapse
- (2021) Shireen Attaran et al. SEMINARS IN CANCER BIOLOGY
- Hypoxia signaling: Challenges and opportunities for cancer therapy
- (2021) Mircea Ivan et al. SEMINARS IN CANCER BIOLOGY
- Tumor microenvironment and cellular senescence: Understanding therapeutic resistance and harnessing strategies
- (2021) Hanxin Liu et al. SEMINARS IN CANCER BIOLOGY
- A Complex Metabolic Network Confers Immunosuppressive Functions to Myeloid-Derived Suppressor Cells (MDSCs) within the Tumour Microenvironment
- (2021) Francesca Hofer et al. Cells
- Immunotherapeutic approaches for small-cell lung cancer
- (2020) Wade T. Iams et al. Nature Reviews Clinical Oncology
- Tumor hypermetabolism confers resistance to immunotherapy
- (2020) Arthur Liu et al. SEMINARS IN CANCER BIOLOGY
- MYC Drives Temporal Evolution of Small Cell Lung Cancer Subtypes by Reprogramming Neuroendocrine Fate
- (2020) Abbie S. Ireland et al. CANCER CELL
- The immunological Warburg effect: Can a metabolic‐tumor‐stroma score (MeTS) guide cancer immunotherapy?
- (2020) Peter J. Siska et al. IMMUNOLOGICAL REVIEWS
- A shift in glutamine nitrogen metabolism contributes to the malignant progression of cancer
- (2020) Manabu Kodama et al. Nature Communications
- Tumor‐Targeted Inhibition of Monocarboxylate Transporter 1 Improves T‐Cell Immunotherapy of Solid Tumors
- (2020) Tongyi Huang et al. Advanced Healthcare Materials
- A Nine-lncRNA signature predicts distant relapse-free survival of HER2-negative breast cancer patients receiving taxane and anthracycline-based neoadjuvant chemotherapy
- (2020) Min Sun et al. BIOCHEMICAL PHARMACOLOGY
- Overcoming acquired resistance to PD-1 inhibitor with the addition of metformin in small cell lung cancer (SCLC)
- (2020) Yeseul Kim et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Lessons learned from understanding chemotherapy resistance in epithelial tubo-ovarian carcinoma from BRCA1and BRCA2mutation carriers
- (2020) Cécile Le Page et al. SEMINARS IN CANCER BIOLOGY
- Risk of Stroke in Cancer Survivors
- (2020) Fangfang Zhang et al. NEUROLOGY
- The predictive power of CD3+ T cell infiltration of oral squamous cell tumors is limited to non-diabetic patients
- (2020) Gerrit Spanier et al. CANCER LETTERS
- Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
- (2019) Jérôme Galon et al. NATURE REVIEWS DRUG DISCOVERY
- Expression and clinical significance of PD-L1, B7-H3, B7-H4 and TILs in human small cell lung Cancer (SCLC)
- (2019) Daniel Carvajal-Hausdorf et al. Journal for ImmunoTherapy of Cancer
- Surgical Resection of SCLC: Prognostic Factors and the Tumor Microenvironment
- (2019) Xiaoliang Zhao et al. Journal of Thoracic Oncology
- Liprin-α4 as a New Therapeutic Target for SCLC as an Upstream Mediator of HIF1α
- (2019) HIDEYA ONISHI et al. ANTICANCER RESEARCH
- Regulation of pH by Carbonic Anhydrase 9 Mediates Survival of Pancreatic Cancer Cells With Activated KRAS in Response to Hypoxia
- (2019) Paul C. McDonald et al. GASTROENTEROLOGY
- Targeting hypoxia-induced carbonic anhydrase IX enhances immune checkpoint blockade locally and systemically
- (2019) Shawn C Chafe et al. Cancer Immunology Research
- Fluorodeoxyglucose uptake is associated with low tumor-infiltrating lymphocyte levels in patients with small cell lung cancer
- (2019) Norimitsu Kasahara et al. LUNG CANCER
- Targeting Pyruvate Kinase M2 and Lactate Dehydrogenase A Is an Effective Combination Strategy for the Treatment of Pancreatic Cancer
- (2019) Goran Hamid Mohammad et al. Cancers
- The Acidic Tumor Microenvironment as a Driver of Cancer
- (2019) Ebbe Boedtkjer et al. Annual Review of Physiology
- Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial
- (2019) Luis Paz-Ares et al. LANCET
- Extracellular pH modulating injectable gel for enhancing immune checkpoint inhibitor therapy
- (2019) Hyung-seung Jin et al. JOURNAL OF CONTROLLED RELEASE
- Pembrolizumab After Two or More Lines of Previous Therapy in Patients With Recurrent or Metastatic SCLC: Results From the KEYNOTE-028 and KEYNOTE-158 Studies
- (2019) Hyun Cheol Chung et al. Journal of Thoracic Oncology
- Lactate/GPR81 signaling and proton motive force in cancer: Role in angiogenesis, immune escape, nutrition, and Warburg phenomenon
- (2019) Timothy P. Brown et al. PHARMACOLOGY & THERAPEUTICS
- Combined VEGF and PD-L1 blockade displays synergistic treatment effects in an autochthonous mouse model of small cell lung cancer
- (2018) Lydia Meder et al. CANCER RESEARCH
- FOXO1: Another avenue for treating digestive malignancy?
- (2018) Feiyu Shi et al. SEMINARS IN CANCER BIOLOGY
- Sweet Killers: NK Cells Need Glycolysis to Kill Tumors
- (2018) Batya Isaacson et al. Cell Metabolism
- First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer
- (2018) Leora Horn et al. NEW ENGLAND JOURNAL OF MEDICINE
- In Vitro and In Vivo Efficacy of the Monocarboxylate Transporter 1 Inhibitor AR-C155858 in the Murine 4T1 Breast Cancer Tumor Model
- (2018) Xiaowen Guan et al. AAPS Journal
- The clinical role of the TME in solid cancer
- (2018) Nicolas A. Giraldo et al. BRITISH JOURNAL OF CANCER
- Targeted hypoxia reduction restores T cell infiltration and sensitizes prostate cancer to immunotherapy
- (2018) Priyamvada Jayaprakash et al. JOURNAL OF CLINICAL INVESTIGATION
- Vascular Targeting to Increase the Efficiency of Immune Checkpoint Blockade in Cancer
- (2018) Maria Georganaki et al. Frontiers in Immunology
- Third-Line Nivolumab Monotherapy in Recurrent SCLC: CheckMate 032
- (2018) Neal Ready et al. Journal of Thoracic Oncology
- Novel carbonic anhydrase IX-targeted therapy enhances the anti-tumour effects of cisplatin in small cell lung cancer
- (2017) Jennifer L Bryant et al. INTERNATIONAL JOURNAL OF CANCER
- Tumor cell-derived lactate induces TAZ-dependent upregulation of PD-L1 through GPR81 in human lung cancer cells
- (2017) J Feng et al. ONCOGENE
- Hypoxia inducible factor HIF-1 promotes myeloid-derived suppressor cells accumulation through ENTPD2/CD39L1 in hepatocellular carcinoma
- (2017) David Kung-Chun Chiu et al. Nature Communications
- Inhibition of HIF-1α enhances anti-tumor effects of dendritic cell-based vaccination in a mouse model of breast cancer
- (2016) Nasim Kheshtchin et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- LDHA-Associated Lactic Acid Production Blunts Tumor Immunosurveillance by T and NK Cells
- (2016) Almut Brand et al. Cell Metabolism
- Hypoxia induces myeloid-derived suppressor cell recruitment to hepatocellular carcinoma through chemokine (C-C motif) ligand 26
- (2016) David Kung-Chun Chiu et al. HEPATOLOGY
- The Effects of Severe Hypoxia on Glycolytic Flux and Enzyme Activity in a Model of Solid Tumors
- (2016) Hannah Smith et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Efficacy of PD-1 Blockade Is Potentiated by Metformin-Induced Reduction of Tumor Hypoxia
- (2016) Nicole E. Scharping et al. Cancer Immunology Research
- Blocking M2 muscarinic receptor signaling inhibits tumor growth and reverses epithelial-mesenchymal transition (EMT) in non-small cell lung cancer (NSCLC)
- (2015) Qingnan Zhao et al. CANCER BIOLOGY & THERAPY
- Neutralization of Tumor Acidity Improves Antitumor Responses to Immunotherapy
- (2015) Shari Pilon-Thomas et al. CANCER RESEARCH
- Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
- (2015) Chih-Hao Chang et al. CELL
- Human anti-CAIX antibodies mediate immune cell inhibition of renal cell carcinoma in vitro and in a humanized mouse model in vivo
- (2015) De-Kuan Chang et al. Molecular Cancer
- Immunological mechanisms of the antitumor effects of supplemental oxygenation
- (2015) Stephen M. Hatfield et al. Science Translational Medicine
- Functional polarization of tumour-associated macrophages by tumour-derived lactic acid
- (2014) Oscar R. Colegio et al. NATURE
- Hypoxia, lipids, and cancer: surviving the harsh tumor microenvironment
- (2014) Daniel Ackerman et al. TRENDS IN CELL BIOLOGY
- Mechanisms of buffer therapy resistance
- (2014) Kate M. Bailey et al. NEOPLASIA
- Posttranscriptional Control of T Cell Effector Function by Aerobic Glycolysis
- (2013) Chih-Hao Chang et al. CELL
- Activity of the Monocarboxylate Transporter 1 Inhibitor AZD3965 in Small Cell Lung Cancer
- (2013) R. Polanski et al. CLINICAL CANCER RESEARCH
- Reprogramming Metabolism with Metformin Improves Tumor Oxygenation and Radiotherapy Response
- (2013) V. E. Zannella et al. CLINICAL CANCER RESEARCH
- Proton pump inhibitor chemosensitization in human osteosarcoma: from the bench to the patients’ bed
- (2013) Stefano Ferrari et al. Journal of Translational Medicine
- Magnetic resonance imaging of tumor glycolysis using hyperpolarized 13C-labeled glucose
- (2013) Tiago B Rodrigues et al. NATURE MEDICINE
- VEGFA/VEGFR2-targeted therapies prevent the VEGFA-induced proliferation of regulatory T cells in cancer
- (2013) Magali Terme et al. OncoImmunology
- Modulation of Microenvironment Acidity Reverses Anergy in Human and Murine Tumor-Infiltrating T Lymphocytes
- (2012) A. Calcinotto et al. CANCER RESEARCH
- Systemic Buffers Inhibit Carcinogenesis in TRAMP Mice
- (2012) Arig Ibrahim-Hashim et al. JOURNAL OF UROLOGY
- Cancer cell growth and survival as a system-level property sustained by enhanced glycolysis and mitochondrial metabolic remodeling
- (2012) Lilia Alberghina et al. Frontiers in Physiology
- HIF-1α effects on angiogenic potential in human small cell lung carcinoma
- (2011) Jun Wan et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells
- (2011) Andrea Facciabene et al. NATURE
- Paclitaxel Plus Bevacizumab in Patients with Chemosensitive Relapsed Small Cell Lung Cancer: A Safety, Feasibility, and Efficacy Study from the Hoosier Oncology Group
- (2010) Shadia Jalal et al. Journal of Thoracic Oncology
- Treatment with HIF-1α Antagonist PX-478 Inhibits Progression and Spread of Orthotopic Human Small Cell Lung Cancer and Lung Adenocarcinoma in Mice
- (2010) Jörg J. Jacoby et al. Journal of Thoracic Oncology
- Bicarbonate Increases Tumor pH and Inhibits Spontaneous Metastases
- (2009) I. F. Robey et al. CANCER RESEARCH
- The Potential Role of Systemic Buffers in Reducing Intratumoral Extracellular pH and Acid-Mediated Invasion
- (2009) A. S. Silva et al. CANCER RESEARCH
- Hypoxia Inducible Factor-1alpha and Vascular Endothelial Growth Factor in Biopsies of Small Cell Lung Carcinoma
- (2009) M. Ioannou et al. LUNG
- Irinotecan or etoposide as front-line therapy for SCLC?
- (2009) Faye M. Johnson et al. Nature Reviews Clinical Oncology
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started